ID   MUM24
AC   CVCL_M521
DR   cancercelllines; CVCL_M521
DR   Wikidata; Q54907077
RX   PubMed=23686003;
CC   Characteristics: Produces IgG kappa.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Unspecified (PubMed=23686003).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
RX   PubMed=23686003; DOI=10.1038/bcj.2013.13; PMCID=PMC3674455;
RA   Hattori Y., Du W.-L., Yamada T., Ichikawa D., Matsunami S.,
RA   Matsushita M.;
RT   "A myeloma cell line established from a patient refractory to
RT   thalidomide therapy revealed high-risk cytogenetic abnormalities and
RT   produced vascular endothelial growth factor.";
RL   Blood Cancer J. 3:e115.1-e115.3(2013).
//